Table 2.
Susceptibility Protocol | Deterministic Protocol | ||||||
---|---|---|---|---|---|---|---|
APOE ε4− (n = 52) | APOE ε4+ (n = 49) | All (n = 101) | Negative (n = 13) | Positive (n = 9) | All (n=22) | ||
Total IES Scores | Mean (SD) | 4.4 (8.8)* | 8.1 (8.7)* | 6.2 (8.9) | 8.2 (11.4) | 9.1 (14.8) | 8.6 (12.6) |
Range | 0–41 | 0–32 | 0–41 | 0–40 | 0–45 | 0–45 | |
Number of persons scoring above clinical significance (%) | 3 (5.8%) | 2 (4.1%) | 5 (5.0%) | 1 (7.7%) | 1 (11.1%) | 2 (9.1%) | |
Intrusion Subscale IES Scores | Mean (SD) | 2.0 (4.9)** | 3.0 (3.5) | 2.5 (4.3) | 5.8 (8.9)** | 5.1 (10.6) | 5.5 (9.4) |
Range | 0–25 | 0–13 | 0–25 | 0–30 | 0–33 | 0–33 | |
Number of persons scoring above clinical significance (%) | 3 (5.8%) | 0 (0.0%) | 3 (3.0%) | 2 (15.4%) | 1 (11.1%) | 3 (13.6%) | |
Avoidance Subscale IES Scores | Mean (SD) | 2.4 (4.7)*** | 5.2 (5.9)*** | 3.7 (5.5) | 2.5 (3.3) | 4.0 (5.8) | 3.1 (4.4) |
Range | 0–24 | 0–22 | 0–24 | 0–10 | 0–13 | 0–13 | |
Number of persons scoring above clinical significance (%) | 2 (3.9%) | 6 (12.2%) | 8 (7.9%) | 0 (0.0%) | 1 (11.1%) | 1 (4.6%) |
significant difference, p = 0.035
significant difference, p = 0.045
significant difference, p = 0.009